Related Experiment Videos
Insights
Iron deficiency in chronic heart failure patients worsens prognosis, leading to reduced quality of life and increased hospitalizations. Early iron treatment, particularly intravenous iron, is crucial for improving outcomes in heart failure management.
Area of Science:
- Cardiology
- Nutritional Science
- Biochemistry
Context:
- Iron deficiency is a common condition in patients with chronic heart failure (CHF).
- It is associated with poorer prognosis, including reduced quality of life and higher rehospitalization rates.
- Understanding iron metabolism in heart failure is critical for effective patient management.
Purpose:
- To highlight the significance of iron deficiency in chronic heart failure.
- To differentiate between absolute and functional iron deficiency in this patient population.
- To review current treatment strategies for iron deficiency in heart failure.
Summary:
- Iron deficiency, distinct from anemia, significantly impacts CHF prognosis.
- Prevalence of anemia in heart failure ranges from 30-50%, increasing with decompensation.
- Intravenous iron administration shows promise, supported by studies like FERRIC HF, FAIR HF, and CONFIRM HF, though oral iron has less evidence.
Impact:
- Effective management of iron deficiency can improve the prognosis for patients with chronic heart failure.
- Focusing on iron status, rather than solely anemia, offers a more targeted therapeutic approach.
- Further research into mortality influences of iron treatment in heart failure is warranted.
Unlabelled:
Iron deficiency is a frequent comorbidity in a patient with chronic heart failure, and it associates with a worse pro-gnosis of that patient. Mainly worse quality of life and more rehospitalizations are in these iron deficient patients. Iron metabolism is rather complex and there is some new information concerning this complexity in heart failure. We distinquish an absolute and a functional iron deficiency in heart failure. It is this deficit which is important and not as much is anemia important here. Prevalence of anaemia in heart failure is about 30-50 %, higher it is in patients suffering more frequently heart failure decompensations. Treatment of iron deficiency is important and it improves prognosis of these patients. Most experiences there are with i.v. iron treatment (FERRIC HF, FAIR HF and CONFIRM HF studies), less so with per oral treatment. There are no clinical trials which analysed mortality influences.
Key Words:
heart failure - iron metabolism in heart failure - prevalence of iron deficit - treatment of iron deficiency in heart failure.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure III: Clinical Manifestations
Pathophysiology of Heart Failure